Clinical Roundup New Century Health and Neighborhood Health Plan of Rhode Island study finds increased hypofractionation uptake April 14, 2023Vol.49 No.15
Clinical Roundup Sylvester investigators identify potential targets to overcome treatment resistance in TNBC March 31, 2023Vol.49 No.13
Clinical Roundup Kisqali phase III NATALEE trial meets primary endpoint at interim analysis demonstrating clinically meaningful benefit in early breast cancer March 31, 2023Vol.49 No.13
Clinical Roundup Study finds diverse differences in microbes in breast tumors from patients of different races March 31, 2023Vol.49 No.13
In Brief Claire L. Streibert named site chief of breast imaging at Fox Chase and Temple Health March 17, 2023Vol.49 No.11
FreeIn the Archives Cancer History Project Panel: How Betty Ford’s and Nancy Reagan’s breast cancer diagnoses changed attitudes to cancer March 10, 2023Vol.49 No.10By Alexandria Carolan
Clinical Roundup Cancer stage and receptor status indicate risk of breast cancer recurrence March 10, 2023Vol.49 No.10
Clinical Roundup Community engagement can help improve clinical trial diversity March 10, 2023Vol.49 No.10
Drugs & Targets FDA broadens indication for Verzenio in HR+, HER2-, node-positive, high-risk early breast cancer March 10, 2023Vol.49 No.10
Drugs & Targets FDA updates mammography regulations to require reporting of breast density information and enhance facility oversight March 10, 2023Vol.49 No.10
